Post by
rjc7 on Jan 29, 2021 9:45pm
About the $5.00/vial estimate...
They may get $5.00/vial until they scale up to full automation. Then the price/vial will drop (who knows to what level). Cameron has said with full automation they can't command the same $/vial. They don't want to appear like they are scalping the market. I'm guessing $3.00/vial. jmho
Comment by
RazeKreations on Jan 29, 2021 10:38pm
Cameron figured that $5 was fair value considering the costs and expertise required. Like he said "we are not selling Kool aid"
Comment by
lscfa on Jan 30, 2021 10:52am
Since Ont. govt. contributed to plant expansion I suspect they will want a discount.
Comment by
buddyboybruce on Jan 30, 2021 4:29pm
Microbix CEO Cameron Groome states $6 per vial. The slide in his presentation reads "$4-6 per vial". Source: 18:30 mark in the following webcast https://www.youtube.com/watch?v=7Bo6LtNp-lo&trk=organization-update-content_share-embed-video_share-article_title
Comment by
lscfa on Jan 31, 2021 3:14pm
Inconsistent with interview on dec 22/2020 where CEO says at end of 2021 the run rate rev will be $36 million.
Comment by
Method on Jan 31, 2021 11:46pm
I believe in that interview, $12m was coming from VTM (based on the 50k/wk inital indicated order), $12m from antigens (assuming somewhat back to normal testing i.e. 2019 run rate) and $12m from QAPs. It sounded like it was their low end target from the various presentations I have listened to from Cameron.